Big pharma war: India slams US for crusading against cheap generics | WHAT REALLY HAPPENED


Big pharma war: India slams US for crusading against cheap generics

Washington’s push for intellectual property rights in the pharma industry is an attack on India’s generic drug trade, New Delhi says as a US government report accuses India of distributing counterfeit drugs worldwide.

Authorities in New Delhi were appalled as the “Special 301 report” published by the United States Trade Representative (USTR) on Saturday pinpointed India – alongside China – as the leading global sources of counterfeit medicines. The document, which reviews the state of intellectual property protection around the world, also alleges that up to 20 percent of drugs sold on the Indian market are fake and represent a danger to public health and safety.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA